Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy
Identifieur interne : 000687 ( Main/Exploration ); précédent : 000686; suivant : 000688Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy
Auteurs : Daisuke Fujiwara [Japon] ; Kenji Takahashi [Japon] ; Takahiro Suzuki [Japon] ; Masakazu Shii [Japon] ; Yukako Nakashima [Japon] ; Sato Takekawa [Japon] ; Atsushi Yoshida [Japon] ; Takashi Matsuoka [Japon]Source :
- Journal of Diabetes Investigation [ 2040-1116 ] ; 2013-11.
Descripteurs français
English descriptors
- KwdEn :
- Asian association, Basal, Basal insulin, Baseline, Baseline treatment, Blood glucose, Body mass index, Characteristic analysis, Clin endocrinol metab, Clinical characteristics, Clinical markers, Cpi2h, Cpi2h suit, Cpr2h, Dcpr, Diabetes, Diabetes care, Diabetes investigation volume, Diabetes mellitus, Disease period, Fasting, Fasting plasma glucose, Fcpr, Fcpr dcpr cpr2h, Glucagon, Glucagon test, Glucose, Glucose toxicity, Glycated hemoglobin, Hba1c, Immunoreactivity, Immunoreactivity indices, Increment, Incretin effect, Insulin, Insulin dose, Insulin injection, Insulin requirement, Insulin secretion, Insulin therapy, Intensive insulin therapy, Islet, Japanese patients, Mellitus, November, Oral agents, Postprandial, Present results, Present study, Progressive disease, Receptor agonist, Regimen, Secretory, Secretory unit, Standard deviation, Therapy, Transplantation, Treatment protocol, Treatment regimen, Wiley publishing asia, Yearly decline.
- Teeft :
- Asian association, Basal, Basal insulin, Baseline, Baseline treatment, Blood glucose, Body mass index, Characteristic analysis, Clin endocrinol metab, Clinical characteristics, Clinical markers, Cpi2h, Cpi2h suit, Cpr2h, Dcpr, Diabetes, Diabetes care, Diabetes investigation volume, Diabetes mellitus, Disease period, Fasting, Fasting plasma glucose, Fcpr, Fcpr dcpr cpr2h, Glucagon, Glucagon test, Glucose, Glucose toxicity, Glycated hemoglobin, Hba1c, Immunoreactivity, Immunoreactivity indices, Increment, Incretin effect, Insulin, Insulin dose, Insulin injection, Insulin requirement, Insulin secretion, Insulin therapy, Intensive insulin therapy, Islet, Japanese patients, Mellitus, November, Oral agents, Postprandial, Present results, Present study, Progressive disease, Receptor agonist, Regimen, Secretory, Secretory unit, Standard deviation, Therapy, Transplantation, Treatment protocol, Treatment regimen, Wiley publishing asia, Yearly decline.
Abstract
Type 2 diabetes is a progressive disease characterized by a yearly decline in insulin secretion; however, no definitive evidence exists showing the relationship between decreased insulin secretion and the need for insulin treatment. To determine the optimal insulin secretory index for identifying patients with non‐obese type 2 diabetes who require multiple daily insulin injection (MDI), we evaluated various serum C‐peptide immunoreactivity (CPR) values.
Url:
DOI: 10.1111/jdi.12103
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000241
- to stream Istex, to step Curation: 000241
- to stream Istex, to step Checkpoint: 000009
- to stream Main, to step Merge: 000736
- to stream Main, to step Curation: 000687
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy</title>
<author><name sortKey="Fujiwara, Daisuke" sort="Fujiwara, Daisuke" uniqKey="Fujiwara D" first="Daisuke" last="Fujiwara">Daisuke Fujiwara</name>
</author>
<author><name sortKey="Takahashi, Kenji" sort="Takahashi, Kenji" uniqKey="Takahashi K" first="Kenji" last="Takahashi">Kenji Takahashi</name>
</author>
<author><name sortKey="Suzuki, Takahiro" sort="Suzuki, Takahiro" uniqKey="Suzuki T" first="Takahiro" last="Suzuki">Takahiro Suzuki</name>
</author>
<author><name sortKey="Shii, Masakazu" sort="Shii, Masakazu" uniqKey="Shii M" first="Masakazu" last="Shii">Masakazu Shii</name>
</author>
<author><name sortKey="Nakashima, Yukako" sort="Nakashima, Yukako" uniqKey="Nakashima Y" first="Yukako" last="Nakashima">Yukako Nakashima</name>
</author>
<author><name sortKey="Takekawa, Sato" sort="Takekawa, Sato" uniqKey="Takekawa S" first="Sato" last="Takekawa">Sato Takekawa</name>
</author>
<author><name sortKey="Yoshida, Atsushi" sort="Yoshida, Atsushi" uniqKey="Yoshida A" first="Atsushi" last="Yoshida">Atsushi Yoshida</name>
</author>
<author><name sortKey="Matsuoka, Takashi" sort="Matsuoka, Takashi" uniqKey="Matsuoka T" first="Takashi" last="Matsuoka">Takashi Matsuoka</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F4BE7AB43AD52FB79AA16927494B1184884C8D5B</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1111/jdi.12103</idno>
<idno type="url">https://api.istex.fr/document/F4BE7AB43AD52FB79AA16927494B1184884C8D5B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000241</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000241</idno>
<idno type="wicri:Area/Istex/Curation">000241</idno>
<idno type="wicri:Area/Istex/Checkpoint">000009</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000009</idno>
<idno type="wicri:doubleKey">2040-1116:2013:Fujiwara D:postprandial:serum:c</idno>
<idno type="wicri:Area/Main/Merge">000736</idno>
<idno type="wicri:Area/Main/Curation">000687</idno>
<idno type="wicri:Area/Main/Exploration">000687</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy</title>
<author><name sortKey="Fujiwara, Daisuke" sort="Fujiwara, Daisuke" uniqKey="Fujiwara D" first="Daisuke" last="Fujiwara">Daisuke Fujiwara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Takahashi, Kenji" sort="Takahashi, Kenji" uniqKey="Takahashi K" first="Kenji" last="Takahashi">Kenji Takahashi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Japon</country>
</affiliation>
</author>
<author><name sortKey="Suzuki, Takahiro" sort="Suzuki, Takahiro" uniqKey="Suzuki T" first="Takahiro" last="Suzuki">Takahiro Suzuki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shii, Masakazu" sort="Shii, Masakazu" uniqKey="Shii M" first="Masakazu" last="Shii">Masakazu Shii</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nakashima, Yukako" sort="Nakashima, Yukako" uniqKey="Nakashima Y" first="Yukako" last="Nakashima">Yukako Nakashima</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Takekawa, Sato" sort="Takekawa, Sato" uniqKey="Takekawa S" first="Sato" last="Takekawa">Sato Takekawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yoshida, Atsushi" sort="Yoshida, Atsushi" uniqKey="Yoshida A" first="Atsushi" last="Yoshida">Atsushi Yoshida</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Matsuoka, Takashi" sort="Matsuoka, Takashi" uniqKey="Matsuoka T" first="Takashi" last="Matsuoka">Takashi Matsuoka</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Diabetes Division, Department of Internal Medicine, Kurashiki Central Hospital, KurashikiOkayama</wicri:regionArea>
<wicri:noRegion>KurashikiOkayama</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Diabetes Investigation</title>
<title level="j" type="alt">JOURNAL OF DIABETES INVESTIGATION</title>
<idno type="ISSN">2040-1116</idno>
<idno type="eISSN">2040-1124</idno>
<imprint><biblScope unit="vol">4</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="618">618</biblScope>
<biblScope unit="page" to="625">625</biblScope>
<biblScope unit="page-count">8</biblScope>
<date type="published" when="2013-11">2013-11</date>
</imprint>
<idno type="ISSN">2040-1116</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">2040-1116</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Asian association</term>
<term>Basal</term>
<term>Basal insulin</term>
<term>Baseline</term>
<term>Baseline treatment</term>
<term>Blood glucose</term>
<term>Body mass index</term>
<term>Characteristic analysis</term>
<term>Clin endocrinol metab</term>
<term>Clinical characteristics</term>
<term>Clinical markers</term>
<term>Cpi2h</term>
<term>Cpi2h suit</term>
<term>Cpr2h</term>
<term>Dcpr</term>
<term>Diabetes</term>
<term>Diabetes care</term>
<term>Diabetes investigation volume</term>
<term>Diabetes mellitus</term>
<term>Disease period</term>
<term>Fasting</term>
<term>Fasting plasma glucose</term>
<term>Fcpr</term>
<term>Fcpr dcpr cpr2h</term>
<term>Glucagon</term>
<term>Glucagon test</term>
<term>Glucose</term>
<term>Glucose toxicity</term>
<term>Glycated hemoglobin</term>
<term>Hba1c</term>
<term>Immunoreactivity</term>
<term>Immunoreactivity indices</term>
<term>Increment</term>
<term>Incretin effect</term>
<term>Insulin</term>
<term>Insulin dose</term>
<term>Insulin injection</term>
<term>Insulin requirement</term>
<term>Insulin secretion</term>
<term>Insulin therapy</term>
<term>Intensive insulin therapy</term>
<term>Islet</term>
<term>Japanese patients</term>
<term>Mellitus</term>
<term>November</term>
<term>Oral agents</term>
<term>Postprandial</term>
<term>Present results</term>
<term>Present study</term>
<term>Progressive disease</term>
<term>Receptor agonist</term>
<term>Regimen</term>
<term>Secretory</term>
<term>Secretory unit</term>
<term>Standard deviation</term>
<term>Therapy</term>
<term>Transplantation</term>
<term>Treatment protocol</term>
<term>Treatment regimen</term>
<term>Wiley publishing asia</term>
<term>Yearly decline</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Asian association</term>
<term>Basal</term>
<term>Basal insulin</term>
<term>Baseline</term>
<term>Baseline treatment</term>
<term>Blood glucose</term>
<term>Body mass index</term>
<term>Characteristic analysis</term>
<term>Clin endocrinol metab</term>
<term>Clinical characteristics</term>
<term>Clinical markers</term>
<term>Cpi2h</term>
<term>Cpi2h suit</term>
<term>Cpr2h</term>
<term>Dcpr</term>
<term>Diabetes</term>
<term>Diabetes care</term>
<term>Diabetes investigation volume</term>
<term>Diabetes mellitus</term>
<term>Disease period</term>
<term>Fasting</term>
<term>Fasting plasma glucose</term>
<term>Fcpr</term>
<term>Fcpr dcpr cpr2h</term>
<term>Glucagon</term>
<term>Glucagon test</term>
<term>Glucose</term>
<term>Glucose toxicity</term>
<term>Glycated hemoglobin</term>
<term>Hba1c</term>
<term>Immunoreactivity</term>
<term>Immunoreactivity indices</term>
<term>Increment</term>
<term>Incretin effect</term>
<term>Insulin</term>
<term>Insulin dose</term>
<term>Insulin injection</term>
<term>Insulin requirement</term>
<term>Insulin secretion</term>
<term>Insulin therapy</term>
<term>Intensive insulin therapy</term>
<term>Islet</term>
<term>Japanese patients</term>
<term>Mellitus</term>
<term>November</term>
<term>Oral agents</term>
<term>Postprandial</term>
<term>Present results</term>
<term>Present study</term>
<term>Progressive disease</term>
<term>Receptor agonist</term>
<term>Regimen</term>
<term>Secretory</term>
<term>Secretory unit</term>
<term>Standard deviation</term>
<term>Therapy</term>
<term>Transplantation</term>
<term>Treatment protocol</term>
<term>Treatment regimen</term>
<term>Wiley publishing asia</term>
<term>Yearly decline</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Diabète</term>
<term>Glucose</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Type 2 diabetes is a progressive disease characterized by a yearly decline in insulin secretion; however, no definitive evidence exists showing the relationship between decreased insulin secretion and the need for insulin treatment. To determine the optimal insulin secretory index for identifying patients with non‐obese type 2 diabetes who require multiple daily insulin injection (MDI), we evaluated various serum C‐peptide immunoreactivity (CPR) values.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Fujiwara, Daisuke" sort="Fujiwara, Daisuke" uniqKey="Fujiwara D" first="Daisuke" last="Fujiwara">Daisuke Fujiwara</name>
</noRegion>
<name sortKey="Matsuoka, Takashi" sort="Matsuoka, Takashi" uniqKey="Matsuoka T" first="Takashi" last="Matsuoka">Takashi Matsuoka</name>
<name sortKey="Nakashima, Yukako" sort="Nakashima, Yukako" uniqKey="Nakashima Y" first="Yukako" last="Nakashima">Yukako Nakashima</name>
<name sortKey="Shii, Masakazu" sort="Shii, Masakazu" uniqKey="Shii M" first="Masakazu" last="Shii">Masakazu Shii</name>
<name sortKey="Suzuki, Takahiro" sort="Suzuki, Takahiro" uniqKey="Suzuki T" first="Takahiro" last="Suzuki">Takahiro Suzuki</name>
<name sortKey="Takahashi, Kenji" sort="Takahashi, Kenji" uniqKey="Takahashi K" first="Kenji" last="Takahashi">Kenji Takahashi</name>
<name sortKey="Takahashi, Kenji" sort="Takahashi, Kenji" uniqKey="Takahashi K" first="Kenji" last="Takahashi">Kenji Takahashi</name>
<name sortKey="Takekawa, Sato" sort="Takekawa, Sato" uniqKey="Takekawa S" first="Sato" last="Takekawa">Sato Takekawa</name>
<name sortKey="Yoshida, Atsushi" sort="Yoshida, Atsushi" uniqKey="Yoshida A" first="Atsushi" last="Yoshida">Atsushi Yoshida</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/LrgpV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000687 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000687 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Lorraine |area= LrgpV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:F4BE7AB43AD52FB79AA16927494B1184884C8D5B |texte= Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy }}
This area was generated with Dilib version V0.6.32. |